freephone 0800 862 0373
Sign in to view your quotes
Email address:
Password or PIN:

Forgotten your password? Reset it here.

Diabetes eye drug given draft approval for NHS by NICE

Published on 04/01/2013

An eye drug for diabetes has been given draft approval for use on the NHS, reversing an earlier decision made by NICE in 2011.

A drug for visual impairment caused by diabetic macular oedema may now be available on the NHS in England and Wales, according to the National Institute for Health and Clinical Excellence (NICE).

Macular oedema is a severe visual impediment, caused when a vein in the retina becomes blocked and leading to inflammation and a build-up of fluid.

In 2011, NICE said that drug ranibizmab, marketed as Lucentis, is too expensive for wide use on the NHS. However, this decision has now been reversed, with NICE issuing draft approval. A final decision on the drug will be made in February.

This announcement follows earlier news that the UK has the fifth highest number of children diagnosed with type 1 diabetes in the world.

Estimates from the International Diabetes Federation have been compiled to create a league table of type 1 diabetes rates from around the globe.

It shows that every year in the UK more than 24 in every 100,000 children aged 14 and younger are diagnosed with the condition. This rate is double that of France and Italy (12.2 and 12.1 per 100,000 respectively).

Only Finland, Sweden, Saudi Arabia and Norway have higher rates than the UK. Unlike type 2 diabetes, type 1 is not linked to obesity of lifestyle, and experts are unclear as to why the figure is so high. Barbara Young, chief executive of Diabetes UK, said:

"We do not fully understand why more children in the UK are developing type 1 diabetes than almost anywhere else in the world. But the fact that the rate is so high here in the UK means it is especially important that parents know the symptoms.”

Symptoms of type 1 diabetes include needing to urinate frequently, increased thirst, extreme tiredness and unexplained weight loss. If left diagnosed and untreated type 1 diabetes can lead to serious illness and even death.

© ActiveQuote Ltd. 2013


Categories:  MedicalNHS and Hospitals
Diabetes eye drug given draft approval for NHS by NICEAn eye drug for diabetes has been given draft approval for use on the NHS, reversing an earlier decision made by NICE in 2011. A drug for v    tweet it on twittershare with your friends on Facebookshare with your friends on MySpaceBlog it on your LinkedIn profile
 

No.1 health insurance broker as rated by customers

Excellent service. Explained everything in detail and really helped to find the right insurance best suited to my needs - which wasn't necessarily the most expensive. 

Review centre member

Good value and the advisor was very helpful and recommended the best policy for my grandson. I would definitely use this service again and recommend to others.

Review centre member

We were contacted in good time to make a knowledgable choice. We were given plenty of options with lots of information to enable us to make the right choice.

Review centre member

The service I received was excellent, the staff member was very efficient and knowledgable. She went out of her way to get the best policy for me.

Review centre member

Great service. I really appreciated the help provided by Active Quote to arrange health insurance. The agent was very informative and proactive. Many thanks!

Review centre member

I received excellent care and attention from the first phone call till the last. Friendly, efficient and patient.

Review centre member

Staff are very helpful, friendly and polite. They call back when they say they will and keep you up to date with progress. Pleasure to deal with.

Review centre member

Very polite and friendly, and gave detailed explanations of all aspects of the cover. Reassuring to know that if you do have a problem there is someone you can contact.

Review centre member

Friendly and efficient. Nothing was too much trouble even when i needed to make a small change, excellent service.

Review centre member

The advisor was incredibly helpful and fully explained the differences between the policies. I really liked the fact that I was put under no pressure.

Review centre member
 
This site is operated by Insurance Broker ActiveQuote Ltd registered in England & Wales company number 6765845.
Authorised and Regulated by the Financial Conduct Authority (FCA). Firm reference number 501109 as detailed on the Financial Services Register. Please read our Key Facts document.
For information about your rights as a consumer visit Citizens Advice.

Our insurance comparison service is free and easy for you to use, but you are responsible for making sure all your information is entered correctly, and for choosing your insurer.

This site uses cookies in order to work correctly - these are not harmful and do not contain personal information. By using this site you consent to this. I understand  Tell me more

please wait ...